J&J faces more lawsuits over all-metal hips; Functional Neuromodulation kicks off DBS trial to treat Alzheimer's;

 @FierceMedDev: The plot thickens in the FDA's surveillance of whistleblowers. More | Follow @FierceMedDev

 @MarkHFierce: Check out the latest preclinical breakthrough news at FierceBiotechResearch. | Follow @MarkHFierce

 @DamianFierce: Mindray Medical rides across-the-board sales growth to a big Q2. More | Follow @DamianFierce

> In Texas, four more plaintiffs have filed lawsuits against Johnson & Johnson's ($JNJ) DePuy unit over its Pinnacle metal-on-metal hip implants. Report

> Functional Neuromodulation launched a clinical trial in the U.S. and Canada that will test deep brain stimulation in patients with mild Alzheimer's disease. Release

> Roche Diagnostics ($RHHBY) is eyeing double-digit growth in India, looking to partner with hospitals and labs to implement its assays. Article

> LabCorp ($LH) has published a validation study of its PCR assay for bacterial vaginosis, available in its NuSwab line of diagnostic tests. Item

> Zynex ($ZXYI), maker of medical devices for electrotherapy and stroke rehabilitation, reported a 19% increase in net revenue for the second quarter, Release

> Teleflex ($TFX) is launching a line of bladeless access ports and closure devices for laparoscopic surgery, designed to make minimally invasive procedures safer and more effective. News

> Researchers are exploring swimming micro-robots that could enable efficient drug delivery. Blog

Biotech News

 @FierceBiotech: Brain signals when 'Special K' will do the trick. More | Follow @FierceBiotech

 @JohnCFierce: Elan now down 12% on bapi fiasco. So does the board have a short list of CEO candidates looking forward to a really tough challenge? | Follow @JohnCFierce

 @RyanMFierce: Not much left at biotech Agennix after talactoferrin failure. More | Follow @RyanMFierce

> Pluristem soars after stem cell drug aids recovery of cancer patient. More

> Bristol-Myers, others track tricky CGRP drug target to beat migraine. Article

> Pfizer, J&J kill PhIII program for key Alzheimer's drug. News

Pharma News

 @FiercePharma: Endo Health's Q2 profits nosedive on Lidoderm patent litigation charge. More | Follow @FiercePharma

> War-torn Syrian drug plants shut down, triggering shortages. Article

> Researchers eye biomarkers for safer Cox inhibitor use. Story

> WSJ: Top FDA officials knew about email surveillance. Report

> J&J faces new marketing probes as Risperdal settlement nears. More

Biotech Research News

> Epilepsy drug boosts brain function in Alzheimer's preclinical tests. News

> HIV viral fragment delivers promising acute liver-failure treatment. Story

> Isis Pharmaceuticals' 'anti-sense' drug combats muscular dystrophy mice. More

> Teva's MLK inhibitor blocks aggressive breast cancer in MSU study. Article

Pharma Manufacturing News

> Manufacturing, pricing problems lead to K-V bankruptcy. Item

> Amneal doubling U.S. capacity, to add 500 jobs. News

> China sweeps in on drug counterfeiters. Report

> Fuji buys DKSH Thailand plant for $53M. News

And Finally... American swimmer and Olympic record-setter Dana Vollmer was diagnosed with a heart rhythm defect at 15, and she and her family decided against getting an implanted cardiac defibrillator. More

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.